Matches in Wikidata for { <http://www.wikidata.org/entity/Q61914959> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- Q61914959 description "assaig clínic" @default.
- Q61914959 description "clinical trial" @default.
- Q61914959 description "clinical trial" @default.
- Q61914959 description "clinical trial" @default.
- Q61914959 description "clinical trial" @default.
- Q61914959 description "ensaio clínico" @default.
- Q61914959 description "ensayo clínico" @default.
- Q61914959 description "ensayu clínicu" @default.
- Q61914959 description "essai clinique" @default.
- Q61914959 description "klinisch onderzoek" @default.
- Q61914959 description "клінічне випробування" @default.
- Q61914959 name "Safety, Tolerability and Efficacy Study of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)" @default.
- Q61914959 type Item @default.
- Q61914959 label "Safety, Tolerability and Efficacy Study of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)" @default.
- Q61914959 prefLabel "Safety, Tolerability and Efficacy Study of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)" @default.
- Q61914959 P1132 Q61914959-9AF08A9F-948A-485A-AF1C-56F73E4D4D0D @default.
- Q61914959 P1476 Q61914959-84629AD8-F3D1-47FA-88DB-F0CC6B5B0E1B @default.
- Q61914959 P17 Q61914959-1E35E38C-E9AE-4250-875B-15A2D7945E9A @default.
- Q61914959 P2899 Q61914959-7C5A46CD-99C8-456C-B02E-7BAFF1EB6D06 @default.
- Q61914959 P3098 Q61914959-94F4F3EE-CBD5-4965-A629-13C5D5CDACF8 @default.
- Q61914959 P31 Q61914959-9D5C807A-ABC1-485D-A9CD-396A750920DD @default.
- Q61914959 P4135 Q61914959-ADDF25F7-AE19-4A31-8DC7-1FBD1D5A72C3 @default.
- Q61914959 P580 Q61914959-B1A057AD-EC27-4C32-A166-80BDB4C60194 @default.
- Q61914959 P582 Q61914959-2135D887-E784-4342-94D6-02FA69371E4E @default.
- Q61914959 P6099 Q61914959-8AC0EBA6-1CBE-40B9-A12C-ABDF9196F92C @default.
- Q61914959 P8363 Q61914959-F3076C7B-CF73-42C2-8361-83A507A3EAA2 @default.
- Q61914959 P1132 "+160" @default.
- Q61914959 P1476 "A Pilot, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study of the Safety, Tolerability and Efficacy of 40 mg QD and 80 mg QD ABT-089 in Adults With Attention Deficit-Hyperactivity Disorder (ADHD)" @default.
- Q61914959 P17 Q30 @default.
- Q61914959 P2899 "+18" @default.
- Q61914959 P3098 "NCT00640185" @default.
- Q61914959 P31 Q30612 @default.
- Q61914959 P4135 "+60" @default.
- Q61914959 P580 "2008-03-01T00:00:00Z" @default.
- Q61914959 P582 "2008-08-01T00:00:00Z" @default.
- Q61914959 P6099 Q42824440 @default.
- Q61914959 P8363 Q78089383 @default.